Fortis Healthcare is trading higher by 4% at Rs 105 in opening trades on reporting 41% year-on-year growth in consolidated net profit at Rs 42 crore for the fourth quarter ended March 2012, on back of strong revenues. Consolidated global revenues more than doubled to Rs 1,279 crore from Rs 421 crore during the quarter under review.
“Operating EBITDA (earnings before interest, taxes, depreciation, and amortization) profit was at Rs 160 crore compared to Rs 58 crore in Q4FY11,” the pharmaceutical company said in a filing.
A combined around 52,000 shares have changed hands on the counter so far on both the exchanges.